Prospective, Randomized, Double Blind, Multicenter Study for Hyalobarrier ® to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG® After Thyroidectomy
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
The percentage of normal esophageal transit in marshmallow esophagography
6 Weeks after intervention
No
Hoon Yub Kim, M.D., Ph.D.
Principal Investigator
Korea University Anam Hospital
Korea: Food and Drug Administration
Hyalobarrier_P3
NCT01696305
December 2012
July 2013
Name | Location |
---|